Peng Cunming, Zheng Anna, Wang Liangliang, Shen Yingjie, Peng Changchun, Yu Jingmou, Shao Shengwen
Zhejiang Provincial Key Laboratory of Vector Biology and Pathogen Control, Huzhou University, Huzhou, 313000, People's Republic of China.
Affiliated Hospital of Jiujiang University, Jiujiang, 332000, People's Republic of China.
Int J Nanomedicine. 2025 Aug 9;20:9857-9881. doi: 10.2147/IJN.S533559. eCollection 2025.
Chondroitin sulfate (CS) is a naturally sulfated glycosaminoglycan with diverse biofunctional properties, including anti-inflammatory effects, reactive oxygen species scavenging, cartilage regeneration and immune regulation. In recent years, CS has shown significant progress in biomedical applications, particularly in drug delivery, tissue engineering, and biosensing. This paper reviews the latest advancements of CS-based nanoplatforms in the biomedical field. CS can be integrated with functional molecules to construct a variety of nanostructures, further expanding its potential applications. CS exhibits distinctive characteristics, and CS-based nanoparticles could serve as promising drug delivery vehicles in tumor therapy. Beyond their roles in drug delivery, CS-based nanoplatforms exhibit transformative potential in tissue engineering, offering promising solutions for wound repair and tissue regeneration. Additionally, CS enhances early disease diagnostics through biomarker detection, leveraging its unique molecular structure and biocompatibility. This comprehensive review explored the properties of CS-based nanoplatforms and their diverse applications, aiming to provide a reference for related research and encourage further advancements in the biomedical fields.
硫酸软骨素(CS)是一种天然硫酸化的糖胺聚糖,具有多种生物功能特性,包括抗炎作用、清除活性氧、软骨再生和免疫调节。近年来,CS在生物医学应用方面取得了显著进展,特别是在药物递送、组织工程和生物传感领域。本文综述了基于CS的纳米平台在生物医学领域的最新进展。CS可以与功能分子整合,构建各种纳米结构,进一步扩展其潜在应用。CS具有独特的特性,基于CS的纳米颗粒可作为肿瘤治疗中有前景的药物递送载体。除了在药物递送中的作用外,基于CS的纳米平台在组织工程中展现出变革潜力,为伤口修复和组织再生提供了有前景的解决方案。此外,CS利用其独特的分子结构和生物相容性,通过生物标志物检测增强早期疾病诊断。这篇综述探讨了基于CS的纳米平台的特性及其多样的应用,旨在为相关研究提供参考,并鼓励生物医学领域的进一步发展。
Int J Nanomedicine. 2025-8-9
Acta Biomater. 2025-5-2
Small Methods. 2024-11-1
J Mater Chem B. 2025-1-22
Carbohydr Polym. 2024-10-15
Carbohydr Polym. 2024-11-15
Drug Deliv Transl Res. 2025-1-29
J Control Release. 2025-5-10
Int J Biol Macromol. 2025-5
Int J Biol Macromol. 2025-4